XXI Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.45M Buy
3,843
+717
+23% +$846K 1.78% 9
2026
Q2
$3.75M Buy
3,126
+86
+3% +$87.9K 1.72% 9
2026
Q1
$2.8M Sell
3,040
-792
-21% -$803K 1.58% 13
2025
Q4
$4.12M Buy
+3,832
New +$3.66M 2.5% 7

Other funds holding LLY

XXI Wealth's LLY Position: Q3 2026 in Review

XXI Wealth increased its Eli Lilly (LLY) stake by 23% in Q3 2026, buying an estimated $846K and bringing the position to 3,843 shares worth $4.45M. The position accounts for 1.78% of the portfolio, ranked #9.

XXI Wealth first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,160 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • XXI Wealth held 3,843 shares of Eli Lilly worth $4.45M as of Q3 2026.
  • XXI Wealth bought 717 Eli Lilly shares in Q3 2026, an estimated $846K.
  • Eli Lilly made up 1.78% of XXI Wealth's portfolio in Q3 2026, its #9 holding.
  • XXI Wealth first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 4,160 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.